High-dose insulin for liver function after surgery
Part of Digestive system clinical trials.
This trial tests if high-dose insulin can help your liver work better and heal faster after a major liver surgery for colorectal cancer that has spread to the liver.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You are scheduled for a major liver resection (removal of part of your liver).
- Your colorectal cancer has spread to your liver and can be removed with surgery.
- You do not have type 1 diabetes.
- Your blood sugar is well-controlled (fasting level 10 mmol/L or lower).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests advanced treatments for cancer that has spread to the liver, either from colon cancer or pancreatic cancer. It may help by targeting liver tumors using treatment plans and, for some participants, liver tissue samples.
This study tests a treatment given before surgery for liver cancer that is at high risk of coming back. You would receive a combination of chemotherapy directly into the liver artery (HAIC), a targeted pill (lenvatinib), and an immunotherapy drug (a PD-1 inhibitor) — if a computer model predicts you might benefit.
This trial uses a test on your tumor (an 'organoid') to pick which medicines might work best for you after surgery. The goal is to lower the chance of your liver cancer coming back.
This trial tests giving two immunotherapy drugs directly into the tumor before surgery for liver cancer. It aims to see if this approach can shrink the tumor and improve outcomes for patients who are candidates for surgery.
This study looks at people with type 2 diabetes who are either waiting for a liver transplant or have already had one. Researchers want to understand how diabetes treatment affects outcomes before and after transplant.
This study combines two surgeries—first removing part of the tumor, then a liver transplant—for patients with advanced liver cancer or liver failure. It aims to offer a chance for cure when standard treatments are not possible.
Hear when a new Liver Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.